These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 188566)

  • 21. Acid beta-glucosidase and the diagnosis of Gaucher's disease in liver and spleen.
    Butterworth J; Broadhead DM
    Clin Chim Acta; 1978 Aug; 87(3):433-40. PubMed ID: 28186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A sensitive fluorimetric assay for serum angiotensin-converting enzyme.
    Friedland J; Silverstein E
    Am J Clin Pathol; 1976 Aug; 66(2):416-24. PubMed ID: 181981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme and lysozyme in silicosis and asbestosis.
    Grönhagen-Riska C; Kurppa K; Fyhrquist F; Selroos O
    Scand J Respir Dis; 1978 Aug; 59(4):228-31. PubMed ID: 211579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement.
    Thi Hong Nguyen C; Kambe N; Kishimoto I; Ueda-Hayakawa I; Okamoto H
    J Dermatol; 2017 Jul; 44(7):789-797. PubMed ID: 28295528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver.
    Owada M; Sakiyama T; Kitagawa T
    Pediatr Res; 1977 May; 11(5):641-6. PubMed ID: 870871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acid phosphatase isoenzymes in Gaucher's disease.
    Mercer DW; Peters SP; Glew RH; Lee RE; Wenger DM
    Clin Chem; 1977; 23(4):631-5. PubMed ID: 844157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis.
    Lieberman J
    Am J Med; 1975 Sep; 59(3):365-72. PubMed ID: 169692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An ACE diagnosis.
    Nasher O; Gupta A
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23417380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The predictive value of serum angiotensin converting enzyme and lysozyme levels in the diagnosis of ocular sarcoidosis.
    Baarsma GS; La Hey E; Glasius E; de Vries J; Kijlstra A
    Am J Ophthalmol; 1987 Sep; 104(3):211-7. PubMed ID: 2820230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 67Ga scintigraphy, serum lysozyme and angiotensin-converting enzyme in pulmonary sarcoidosis.
    Alberts C; van der Schoot JB; van Daatselaar JJ; Braat MC; Roos CM
    Eur J Respir Dis; 1983 Jan; 64(1):38-46. PubMed ID: 6297943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gaucher's disease in Lithuania: its diagnosis and treatment.
    Kleinotienė G; Tylki-Szymanska A; Czartoryska B
    Medicina (Kaunas); 2011; 47(7):405-11. PubMed ID: 22112991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
    Basu A; Prence E; Garrett K; Glew RH; Ellingson JS
    Arch Biochem Biophys; 1985 Nov; 243(1):28-34. PubMed ID: 3933429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gaucher's disease: rare presentation of a rare disease.
    Shrestha B; Devgan A; Sharma M
    J Child Neurol; 2013 Oct; 28(10):1296-8. PubMed ID: 22914376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme replacement therapy in Gaucher's disease: preliminary clinical trial of a new enzyme preparation.
    Beutler E; Dale GL; Guinto DE; Kuhl W
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4620-3. PubMed ID: 200923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukocyte glucocerebrosidase deficiency diagnostic in adult Gaucher's disease with negative bone marrow biopsy. Some properties of the enzyme in leukocytes and spleen.
    Klibansky C; Hoffmann J; Pinkhas J; Algom D; Dintzman M; Ben-Bassat M; De Vries A
    Eur J Clin Invest; 1974 Apr; 4(2):101-7. PubMed ID: 4832717
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased circulating levels of transcobalamin ii in gaucher's disease.
    Gilbert HS; Weinreb N
    N Engl J Med; 1976 Nov; 295(20):1096-101. PubMed ID: 62278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gaucher's disease--ocular manifestation and treatment].
    Filipek E; Koraszewska-Matuszewska B
    Klin Oczna; 2006; 108(7-9):357-60. PubMed ID: 17290842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.
    Cox T; Lachmann R; Hollak C; Aerts J; van Weely S; Hrebícek M; Platt F; Butters T; Dwek R; Moyses C; Gow I; Elstein D; Zimran A
    Lancet; 2000 Apr; 355(9214):1481-5. PubMed ID: 10801168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An adult form of type-I. Gaucher's disease].
    Múzes G; Pitlik E; Gohér A; Somogyi A; Tulassay Z
    Orv Hetil; 2000 Mar; 141(13):669-73. PubMed ID: 10774238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum lysozyme levels and clinical features of sarcoidosis.
    Tomita H; Sato S; Matsuda R; Sugiura Y; Kawaguchi H; Niimi T; Yoshida S; Morishita M
    Lung; 1999; 177(3):161-7. PubMed ID: 10192763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.